Gender differences in injection risk behaviors at the first injection episode

https://doi.org/10.1016/j.drugalcdep.2006.12.021Get rights and content

Abstract

Objectives

To examine gender differences in drug injection equipment sharing at injecting initiation.

Methods

Young injecting drug users (IDUs) in New York City February 1999–2003 were surveyed about injection risk behaviors and circumstances at initiation. Analyses were gender-stratified and excluded participants who initiated alone. Multiple logistic regression estimated adjusted odds ratios.

Results

Participants (n = 249) were 66% male and 82% White. Mean initiation age was 19.2; mean years since initiating was 3.0. Women were significantly more likely to cite social network influence as a reason for initiating, to have male and sex partner initiators, and to share injecting equipment than men. Among women, sharing any injection equipment was associated with initiation by a sex partner and having ≥2 people present. Among men, being injected by someone else predicted sharing any injection equipment, while using a legally obtained syringe was protective.

Conclusions

Social persuasion stemming from sexual and/or social relationships with IDUs may increase women's risk of sharing injection equipment at initiation, and consequently, their early parenteral risk of acquiring blood-borne infections. Interventions should focus on likely initiates, especially women in injecting-discordant sex partnerships, and IDUs (potential initiators).

Introduction

Many new injecting drug users (IDUs) are at risk of infection with blood-borne infections such as HIV, the Hepatitis B virus (HBV) and the Hepatitis C virus (HCV) within their first few years of initiating injecting (Friedman et al., 1989, Nicolosi et al., 1992, Garfein et al., 1996, Fennema et al., 1997, Doherty et al., 2000a). Female new IDUs, in particular, may be at increased risk for early infection. Studies in New York City (NYC), for instance, have found higher HIV seroprevalence among female new IDUs than among male new IDUs (Friedman et al., 1993, Des Jarlais et al., 1999), and female new IDUs in NYC have also been found to be significantly more likely to be infected with HCV than male IDUs (Neaigus et al., 2007). The very first injection has increasingly been recognized as a potentially vulnerable time for the transmission of blood-borne infections. While a growing number of studies have examined circumstances around the first injection episode (Hser et al., 1987, Stenbacka, 1990, Crofts et al., 1996, Atwood, 1999, Doherty et al., 2000b, Roy et al., 2002), and the relationship of these circumstances to current risk behavior (Chitwood et al., 2000, Vidal-Trecan et al., 2002, Treloar et al., 2003, Novelli et al., 2005), little is known about gender differences in injection risk behavior at the initiation event, and the circumstances that may be associated with such risk. Interventions targeted at preventing infection among those non-injecting drug users who may be at risk of transitioning to injecting, such as individuals in injecting-discordant relationships, require information that can help elucidate the social and circumstantial predictors of infection risk at injecting initiation, and how these predictors may vary by gender.

Initiates to injecting are at high risk of infection during the first injecting event for a variety of reasons. The first injection event is often unplanned (Crofts et al., 1996, Doherty et al., 2000b, Vidal-Trecan et al., 2002, Treloar et al., 2003), and thus initiates may not have opportunity to obtain either clean syringes or clean drug preparation equipment, such as cookers used to mix and heat the drugs, cottons used to filter out the drug's impurities, or water used to dissolve the drugs or rinse equipment. Inexperienced injectors may also be ill-informed regarding the risks associated with sharing injection paraphernalia due to their lower levels of contact with harm reduction services (Treloar et al., 2003). Moreover, initiates may be subject to the influence of their initiators, many of whom may be more likely to have previously engaged in injection risk behavior (Kral et al., 1999, Day et al., 2005) and thus may be high risk sharing partners.

Gender may be an additional determinant of risk-taking behavior at injecting initiation. Many studies have found that female IDUs were more likely than men to have been initiated by male sexual partners (Powis et al., 1996, Crofts et al., 1996, Diaz et al., 2002, Evans et al., 2003). Several studies of IDUs’ injecting behavior have shown that it is common for women to use syringes and ancillary drug preparation equipment after men have used them to inject themselves (Sotheran et al., 1992, Davies et al., 1996, Bennett et al., 2000). Others have found that sharing drug injecting equipment is frequent among women who have injecting sex partners (Barnard, 1993, Neaigus et al., 1995, MacRae and Aalto, 2000, Evans et al., 2003, Tortu et al., 2003).

In the following, we describe the circumstances of injecting initiation in a sample of young, predominantly White, new IDUs recruited in New York City, and compare by gender the influence of the circumstances of initiating injecting on the prevalence of injection risk behavior at the initiation event. We evaluate the hypotheses that women are more likely to engage in injection risk behavior at the first injection, and that the correlates of injection risk at initiation will vary by gender.

Section snippets

Recruitment, eligibility and procedures

Between February 1999 and February 2003, 279 new IDUs were non-treatment recruited in the East Village/Lower East Side area of New York City for a study examining the prevalence and risk factors for infection with HIV, HBV and HCV; this study was a sub-study of a larger longitudinal analysis of transitions to injecting among non-injecting heroin users (Neaigus et al., 2006). Participants were recruited using ethnographic social mapping, targeted sampling, street outreach and chain-referral

Sample demographic and drug injecting characteristics

Two thirds of the 249 participants were male (Table 1). Most self-identified as being of white race/ethnicity, half were low income, almost half had not graduated high school, and over half were homeless. The mean age was 22.6 years (standard deviation (S.D.) = 3.2 years); males were on average one year older than females. A small percentage of the sample (1.7%) was infected with HIV. Men were significantly more likely to have been HBV infected than women (22.4% versus 10.4%), and women were

Discussion

This study found that the circumstances of injecting initiation, and injection risk behavior at the initiation event, differed for women and men in ways that may have important implications for disease transmission. Though syringe sharing was rare, the sharing of drug preparation equipment was common, especially among women. The female new IDUs in our study thus placed themselves at higher risk of acquiring drug-mediated pathogens early in their injecting careers. For both men and women,

Conclusion

The first drug injection is a critical one. Not only may many initiates, particularly women, be more likely to share injecting equipment the first time they inject, but future injection related risk behaviors may also be established during this time (Novelli et al., 2005). Interventions should adopt a two-pronged approach, aiming to prevent the transition to injecting drug use, while also providing current and potential IDUs with both skills and resources to protect themselves from infection.

Acknowledgements

The study was funded by the United States National Institute on Drug Abuse, grant DA09920 “Non-Injecting Heroin Users, New Injectors and HIV Risk” (Principal Investigator: Alan Neaigus). We would like to thank Gilbert Ildefonso, Stephen J. Sifaneck, Jesse DeJesus, Peter Blasko, and other members of the research staff who have worked on the study. This research would not have been possible without the consent of the drug users who agreed to participate in this study.

References (50)

  • C.A. Day et al.

    Initiation to heroin injecting among heroin users in Sydney, Australia: cross sectional survey

    Harm. Reduct. J.

    (2005)
  • D.C. Des Jarlais et al.

    AIDS and the transition to illicit drug injection: results of a randomized trial prevention program

    Br. J. Addiction

    (1992)
  • D.C. Des Jarlais et al.

    Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City

    J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.

    (1999)
  • T. Diaz et al.

    Sex-specific differences in circumstances of initiation into injection-drug use among young adult Latinos in Harlem, New York City

    AIDS Behav.

    (2002)
  • M.C. Doherty et al.

    Correlates of HIV infection among young adult short-term injection drug users

    AIDS

    (2000)
  • M.C. Doherty et al.

    Gender differences in the initiation of injection drug use among young adults

    J. Urban Health

    (2000)
  • J.L. Evans et al.

    Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study)

    J. Urban Health

    (2003)
  • J.S. Fennema et al.

    Young and recent-onset injecting drug users are at higher risk for HIV

    Addiction

    (1997)
  • V.M. Frajzyngier et al.

    The social environment of HIV/HCV risk: a comparison of geographically mobile and geographically stable young, new injectors in New York City

  • S.R. Friedman et al.

    AIDS and the new drug injector

    Nature

    (1989)
  • S.R. Friedman et al.

    Female injecting drug users get infected sooner than males

  • J.F. Gamella

    The spread of intravenous drug use and AIDS in a neighborhood in Spain

    Med. Anthropol. Q.

    (1994)
  • R.S. Garfein et al.

    Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T- lymphotropic viruses

    Am. J. Public Health

    (1996)
  • H. Hagan et al.

    Sharing of drug preparation equipment as a risk factor for hepatitis C

    Am. J. Public Health

    (2001)
  • J.A. Hahn et al.

    Hepatitis C virus seroconversion among young injection drug users: relationships and risks

    J. Infect. Dis.

    (2002)
  • Cited by (102)

    • Injecting drug use: Gendered risk

      2018, International Journal of Drug Policy
    View all citing articles on Scopus
    View full text